Impact of sICAM-1 Overexpression on Inflammation and Survival in Pneumonia
Author Information
Author(s): Mendez Michael P, Monroy Yeni K, Du Ming, Preston Angela M, Tolle Leslie, Lin Yujing, VanDussen Kelli L, Samuelson Linda C, Standiford Theodore J, Curtis Jeffery L, Beck James M, Christensen Paul J, Paine Robert III
Primary Institution: Henry Ford Health System
Hypothesis
Overexpression of sICAM-1 in the alveolar space modulates the innate immune response and alters the response to pulmonary infection.
Conclusion
Alveolar sICAM-1 modulates pulmonary inflammation, and manipulating ICAM-1 interactions may affect the host response to Gram negative pulmonary infections.
Supporting Evidence
- SPC-sICAM-1 mice showed increased mortality and systemic dissemination of bacteria compared to wild-type mice.
- Inflammatory responses were significantly increased in SPC-sICAM-1 mice.
- SPC-sICAM-1 mice had a higher percentage of positive spleen cultures indicating systemic infection.
Takeaway
When mice have too much sICAM-1 in their lungs, they get sicker and die faster from pneumonia because their bodies can't fight the infection as well.
Methodology
Transgenic mice overexpressing sICAM-1 were compared to wild-type mice after being infected with K. pneumoniae.
Limitations
The study's transgenic design may minimize the endogenous regulation of sICAM-1, potentially leading to exaggerated inflammation.
Statistical Information
P-Value
0.0012
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website